REPICE, ANNA MARIA RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.074
EU - Europa 1.717
AS - Asia 617
SA - Sud America 2
AF - Africa 1
Totale 4.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.069
PL - Polonia 558
IE - Irlanda 328
IT - Italia 304
SE - Svezia 225
CN - Cina 206
HK - Hong Kong 159
RU - Federazione Russa 135
JO - Giordania 87
SG - Singapore 83
DE - Germania 31
CH - Svizzera 27
UA - Ucraina 26
GB - Regno Unito 25
IR - Iran 22
SA - Arabia Saudita 21
FI - Finlandia 16
ES - Italia 12
IN - India 12
FR - Francia 11
TR - Turchia 10
VN - Vietnam 10
KR - Corea 7
BE - Belgio 6
CA - Canada 5
CZ - Repubblica Ceca 5
AT - Austria 3
NL - Olanda 3
LT - Lituania 2
BR - Brasile 1
CL - Cile 1
SC - Seychelles 1
Totale 4.411
Salva come PNG Salva come JPEG
Città #
Warsaw 558
Dublin 328
Chandler 284
Fairfield 275
Ashburn 146
Hong Kong 112
Lawrence 106
Altamura 101
Woodbridge 101
Seattle 96
Beijing 90
Houston 85
Cambridge 76
Princeton 72
Wilmington 71
Ann Arbor 61
Florence 59
Buffalo 58
Milan 57
Singapore 55
Boston 52
Kent 51
Dearborn 37
Shanghai 37
Jacksonville 30
Bern 27
Moscow 27
New York 26
San Diego 24
Medford 23
Riyadh 19
Norwalk 15
Barcelona 12
Boardman 12
Falls Church 11
Los Angeles 9
Dong Ket 8
Istanbul 8
Rome 8
Bremen 7
Guangzhou 7
Seoul 7
Amman 6
Brussels 6
Hefei 6
London 6
West Jordan 6
Brno 5
Nanjing 5
Tehran 5
Hillsboro 4
Kunming 4
Lappeenranta 4
Phoenix 4
Pune 4
Redmond 4
Andover 3
Chennai 3
Foggia 3
Fuzhou 3
Genoa 3
Hangzhou 3
Mumbai 3
Redwood City 3
Toronto 3
Vienna 3
Wuhan 3
Auburn Hills 2
Bologna 2
Buraidah 2
Campi Bisenzio 2
Chengdu 2
Faenza 2
Forlì 2
Forney 2
Izmir 2
Jinan 2
Lyon 2
Notaresco 2
Palermo 2
Pescara 2
San Giuliano Terme 2
Scandicci 2
Taranto 2
Vilnius 2
Amsterdam 1
Arezzo 1
Bangalore 1
Berlin 1
Bielefeld 1
Carate Brianza 1
Castelliri 1
Frankfurt am Main 1
Gunzenhausen 1
Hanover 1
Hebei 1
Heinrichsthal 1
Helsinki 1
Houplin-Ancoisne 1
Hyderabad 1
Totale 3.401
Salva come PNG Salva come JPEG
Nome #
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients. 224
Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. 221
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 221
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 204
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies 109
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 104
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 101
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 99
Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. 89
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 87
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. 86
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance 82
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience 80
Disappearance of motor tics after Wernicke's encephalopathy in a patient with Tourette's syndrome 78
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 76
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging. 73
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 71
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 67
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 63
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 63
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 61
Association of celiac disease in patients with multiple sclerosis in Tuscany 60
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 59
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 58
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 57
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 57
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 55
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 52
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 49
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 49
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 48
Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis 48
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 46
Leptomeningeal enhancement analysis in diagnostic clinical setting 45
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 45
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 44
Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation 43
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging. 43
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 43
Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity 43
CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis 43
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 43
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 42
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume 41
Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis 41
Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions 41
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 41
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course 41
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 40
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 40
Absence of association between intronic polymorphism in PS-1 gene and alzheimer's disease in italian patients 40
Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients 40
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 40
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 40
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg 39
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 39
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 38
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 37
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 37
Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis 37
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 36
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 36
Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene (MAG) and study of their association with multiple sclerosis. 35
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 35
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 35
MMP9 index as possible diagnostic marker of Neuro-Behcet's disease 34
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 34
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 34
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 33
Direct comparison of Azathioprine and Interferon beta 1a efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis 32
Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis 31
Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis 24
Cyclophosphamide pulses therapy after natalizumab discontinuation in Multiple Sclerosis patients 24
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 23
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis 22
Case report: A multiple sclerosis patient with imaging features of glymphatic failure benefitted from CSF flow shunting 20
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis 15
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 14
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 11
Totale 4.531
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020663 0 29 15 59 86 67 87 79 61 84 82 14
2020/2021466 40 41 16 62 59 50 26 36 37 59 16 24
2021/2022444 7 46 23 33 14 13 13 47 22 15 72 139
2022/20231.424 104 268 99 53 95 247 193 83 194 3 47 38
2023/2024750 23 94 84 53 67 82 36 135 18 42 74 42
2024/2025231 190 41 0 0 0 0 0 0 0 0 0 0
Totale 4.531